Dr. Foluso Ademuyiwa, M.D.
Claim this profileWashington University School of Medicine
Area of expertise
Breast Cancer
Foluso Ademuyiwa, M.D. has run 7 trials for Breast Cancer. Some of their research focus areas include:
HER2 Negative
Foluso Ademuyiwa, M.D. has run 1 trial for HER2 Negative.
Affiliated Hospitals
Washington University School Of Medicine
Siteman Cancer Center At West County Hospital
Clinical Trials Foluso Ademuyiwa, M.D. is currently running
Zunsemetinib + Capecitabine
for Breast Cancer
This is a phase Ib/II study evaluating the safety and efficacy of zunsemetinib (ATI-450) with capecitabine in patients with hormone receptor-positive and HER2-negative (HR+/HER2-) metastatic breast cancer (MBC).
Recruiting
1 award
Phase 1 & 2
6 criteria
RNA Disruption Assay
for Breast Cancer
This trial tests a new method called RNA Disruption Assay to see if it can help doctors determine early on if breast cancer patients' tumors are responding to chemotherapy. By analyzing the tumor's RNA, the test aims to guide treatment decisions and improve patient outcomes.
Recruiting
1 award
N/A
7 criteria
More about Foluso Ademuyiwa, M.D.
Clinical Trial Related
1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Foluso Ademuyiwa, M.D. has experience with
- Carboplatin
- RNA Disruption Assay (RDA)
- Cisplatin
- DiviTum® TKa Assay
- Study Care Plans
- Mammaglobin-A DNA Vaccine
Breakdown of trials Foluso Ademuyiwa, M.D. has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Foluso Ademuyiwa, M.D. specialize in?
Foluso Ademuyiwa, M.D. focuses on Breast Cancer and HER2 Negative. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are Stage IV.
Is Foluso Ademuyiwa, M.D. currently recruiting for clinical trials?
Yes, Foluso Ademuyiwa, M.D. is currently recruiting for 4 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Foluso Ademuyiwa, M.D. has studied deeply?
Yes, Foluso Ademuyiwa, M.D. has studied treatments such as Carboplatin, RNA Disruption Assay (RDA), Cisplatin.
What is the best way to schedule an appointment with Foluso Ademuyiwa, M.D.?
Apply for one of the trials that Foluso Ademuyiwa, M.D. is conducting.
What is the office address of Foluso Ademuyiwa, M.D.?
The office of Foluso Ademuyiwa, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.